With two decades of experience in the financial sector, Matt Eitner has held leadership positions at numerous investment firms, including Aegis Capital Corporation and Casimir Capital, LP, both based in New York City. Since 2011, Matt Eitner has served as the chief executive officer of Laidlaw & Company, also in New York City. At Laidlaw, he manages client relationships while also overseeing several initial public offerings (IPOs).
Most recently, Laidlaw served as the sole book-running manager for BioSig Technologies’ IPO. The $10 million dollar offering, which closed on February 25, 2020, included the sale of up to 2,500,000 common stock shares, each of which was valued at $0.001.
Speaking about the investment, BioSig noted that the funds raised will be used for scaling up clinical and commercial operations and for developing and securing new patents. In addition to research and development related to new products, the firm will also be using the funds for general corporate purposes and working capital.
